About Biorasis
Biorasis is a company based in Mansfield (United Kingdom) founded in 2007. Biorasis has raised $3 million across 10 funding rounds from investors including HHS, MassChallenge and Helmsley Charitable Trust. Biorasis offers products and services including GLUCOWIZZARD and Metabolic Monitoring Platform. Biorasis operates in a competitive market with competitors including Dexcom, Livongo, Bigfoot Biomedical, Senseonics and One Drop, among others.
- Headquarter Mansfield, United Kingdom
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
- Legal Name Biorasis, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$3 M (USD)
in 10 rounds
-
Latest Funding Round
$3 M (USD), Series A
Nov 14, 2018
-
Investors
HHS
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Biorasis
Biorasis offers a comprehensive portfolio of products and services, including GLUCOWIZZARD and Metabolic Monitoring Platform.
Miniaturized device for reading and transmitting glucose levels wirelessly.
Platform for real-time continuous monitoring of metabolic indicators.
Funding Insights of Biorasis
Biorasis has successfully raised a total of $3M across 10 strategic funding rounds. The most recent funding activity was a Series A round of $3 million completed in November 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Biorasis
Biorasis has secured backing from 4 investors, including venture fund and institutional investors. Prominent investors backing the company include HHS, MassChallenge and Helmsley Charitable Trust.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early-stage entrepreneurs are accelerated through MassChallenge's program.
|
Locked | Locked | Locked | |
|
A charitable trust focused on healthcare and research funding.
|
Locked | Locked | Locked | |
|
Public health and human services are overseen by HHS.
|
Locked | Locked | Locked |
Investor details for Biorasis
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Biorasis
Investment portfolio details for Biorasis
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Biorasis
Detailed financials for Biorasis
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Biorasis Comparisons
Peer comparison for Biorasis
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Biorasis
Biorasis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Dexcom, Livongo, Bigfoot Biomedical, Senseonics and One Drop, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Wearable glucose monitoring patches are provided for real-time data tracking.
|
|
| Locked | Locked | Locked |
Provider of smart devices for diabetes management for patients and doctors
|
|
| Locked | Locked | Locked |
Developer of a closed-loop automated insulin delivery system
|
|
| Locked | Locked | Locked |
Implantable continuous glucose monitoring systems are provided for diabetes management.
|
|
| Locked | Locked | Locked |
Provider of workforce healthcare solutions
|
|
| Locked | Locked | Locked |
Gamified apps for diabetes management and therapy are provided.
|
Detailed competitors of Biorasis
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Biorasis
Complete news archive for Biorasis
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Biorasis
Biorasis was founded in 2007 and raised its 1st funding round 2 years after it was founded.
Biorasis is headquartered in Mansfield, United Kingdom. It is registered at Mansfield, England, United Kingdom.
Biorasis is a funded company, having raised a total of $3M across 10 funding rounds to date.
Biorasis was founded in 2007 and is based in Mansfield, United Kingdom. Operations focus on the medical device sector, where a sensor platform for continuous glucose monitoring is developed. Glucose levels are read by a tiny sensor and transmitted to personal digital accessories like smartphones or computers. An implantable multi-sensor platform is also offered for real-time, continuous monitoring of vital signs.
Biorasis's top competitors include Dexcom, Senseonics and Bigfoot Biomedical.
Biorasis offers GLUCOWIZZARD and Metabolic Monitoring Platform.
Biorasis has 4 investors. Key investors include HHS, MassChallenge, Helmsley Charitable Trust, and National Science Foundation.